Cuba on Thursday continues the clinical trials on the vaccine candidate against Covid-19, known as Soberana 01 (Sovereign 01), with a second group of 20 volunteers aged 60 to 80.

 

After the favorable development on the first days of the stage of clinical trials with Soberana 01, Cuba announces the work on a new COVID-19 vaccine candidate.

 

The Holguín Territorial Center for Attention to Infertile Couples achieved about 200 pregnancies through low complexity treatments in the first seven months of the year, despite facing resource limitations and in the midst of the COVID-19 pandemic.